Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: Medicare, Medicaid and Other US Government Payers Perspectives: The ISPOR Drug Cost Task Force Report—Part IV
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2005 ◽
Vol 8
(5)
◽
pp. 521-533
◽
2009 ◽
Vol 12
(8)
◽
pp. 1075-1083
◽
Keyword(s):
2009 ◽
Vol 12
(8)
◽
pp. 1053-1061
◽